1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsTCR Sequencing Grant Program is sponsored by ImmuneWatch × QIAGEN. This program provides support for longitudinal bulk TCR sequencing projects, focusing on TCR clone expansion or contraction and antigen-specificity linked to disease or treatment response.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
TCR Sequencing Grant Program — ImmuneWatch × QIAGEN Now Open for Applications Free TCR Sequencing & Analysis for Your Research ImmuneWatch and QIAGEN are funding up to 4 research projects - 2 from academia, 2 from for-profit - at no cost to you. Apply Now Check Eligibility Application deadline: October 30, 2026 Not Sure Yet?
Join Our Free Webinar See how ImmuneWatch approaches TCR sequencing projects and get live answers on eligibility and the application process. No commitment to apply. Register for the Webinar 2 September 2026 · 16:00–17:00 CEST · 10:00–11:00 AM ET · 07:00–08:00 AM PT · Free to join What Selected Projects Receive QIAGEN RNA extraction kit shipped directly to your lab, ready to process your samples.
TCR-seq Library Construction Bulk-TCR-seq library preparation using the QIAseq Targeted RNA TCR Panel. NGS Sequencing & Processing Full next-generation sequencing and clonotype data processing, delivered by QIAGEN. TCR Intelligence Services Expert TCR clustering and antigen–TCR annotations with ImmuneWatch DETECT by the ImmuneWatch analyst team.
Longitudinal bulk TCR sequencing TCR clone expansion or contraction Antigen-specificity linked to disease or treatment response Immune monitoring of immunotherapy, cell therapy, or vaccines Academic, non-profit, or biopharma — non-profit and for-profit applicants evaluated separately.
USA, Canada, UK, Ireland, Germany, France, Italy, Austria, Switzerland, Netherlands, Belgium, Poland, Finland, Sweden, Denmark, Norway Human RNA (RIN > 5, ≥ 0. 1 ng/µL) from solid tumor, enriched TILs, peripheral blood, or buffy coat. Samples must already be collected.
Up to 24 samples per grant award Must be able to extract and ship RNA on dry ice to Germany or USA Project completed within 6 months of selection Willingness to share applicant details and results for winner announcements and other communications related to the grant program Scientific merit, clinical relevance, and project feasibility One-page form covering study title, abstract, methods, and expected outcomes.
Deadline October 30, 2026. Assessed on scientific quality, innovation, and speed of execution. November 15, 2026 — up to 4 projects selected, followed by a public announcement.
Kits shipped, sequencing begins, results delivered within 6 months of selection. Start Your Application Read the full rules Up to 4 projects funded. Deadline October 30, 2026.
Non-profit and for-profit applicants evaluated separately. Apply Now Questions? grant@immunewatch.
com
According to the current listing, eligibility includes: Academic, non-profit, or biopharma institutions in the USA, Canada, UK, Ireland, Germany, France, Italy, Austria, Switzerland, Netherlands, Belgium, Poland, Finland, Sweden, Denmark, Norway. Confirm the full requirements in the official notice before applying.
Applications for TCR Sequencing Grant Program are due October 30, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
TCR Sequencing Grant Program is funded by ImmuneWatch × QIAGEN. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.